Higher prevalence of fundus haemorrhages in early-screened (NEST Study) as compared to late-screened (SUNDROP Study) newborn populations
- PMID: 33514529
- DOI: 10.1136/bjophthalmol-2020-317908
Higher prevalence of fundus haemorrhages in early-screened (NEST Study) as compared to late-screened (SUNDROP Study) newborn populations
Abstract
Background/aims: To determine whether timing of ophthalmic screening influences prevalence of neonatal fundus haemorrhages. We compared the prevalence of fundus haemorrhages in two populations: term newborns screened early (less than 72 hours) and preterm newborns screened late (4-11 weeks). Additionally, we reviewed the literature on timing and prevalence of newborn haemorrhages.
Methods: Retrospective observational cohort study. Infants who underwent wide-angle ophthalmic digital imaging over one overlapping year in the Newborn Eye Screen Testing (NEST) or Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) programme were included. The PubMed database was filtered to include English-language articles dating back to 1950. Nine articles were selected for review based on inclusion of the prevalence of newborn fundus haemorrhages at multiple time points.
Results: A total of 202 patients received early imaging in the NEST cohort and 73 patients received late imaging in the SUNDROP cohort. In the NEST cohort, 20.2% of newborns had haemorrhages. In contrast, we found haemorrhages in only one case or 1.4% of the SUNDROP cohort. Using prevalence data from nine additional studies, we developed a predicted probabilities model of newborn haemorrhages. Per this model, the probability of seeing a haemorrhage if you screen an infant at 1 hour is 18.8%, at 2 weeks is 2.9% and at 1 month is 0.28%.
Conclusion: We found a significant difference in the prevalence of fundus haemorrhages between the early-screened NEST cohort and the late-screened, preterm SUNDROP cohort. Likely, this difference is due to the transient nature of most newborn haemorrhages.
Keywords: child health (paediatrics); epidemiology; imaging; public health; retina.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Darius M. Moshfeghi: 1-800 Contacts (Board of Directors, equity), Akceso Advisors AG (Evaluation of DME Market), Alcon (Consultant), Alexion (Senior consultant), Allegro (SAB), Apellis (Site PI), Bayer Pharma AG (ROP Imaging Committee), CMEOutfitters.com (CME consultant), dSentz, Inc. (Founder, Board of Directors, equity), Genentech (Proper Grant 2019). Iconic Therapeutics (Steering Committee), Irenix(SAB), Grand Legend Technology, LTD (Equity), Linc (Founder, Equity, Board of Directors), M3 GLOBAL RESEARCH (Consultant), NORTHWELL HEALTH (Grand Rounds), Novartis Pharmaceuticals (Data Safety Monitoring Boardx3 (Hawk/Harrier, Kite/Kestrel, China nAMD/DME), Pediatric Advisory Board, Safety Review Committee), Ocular Surgery News (Consultant), Placid0 (Founder, equity, Board of Directors), Pr3vent (Founder, Board of Directors, equity), Praxis UNS (Consultant), Prime Medical Education (CME consultant), Promisight (Founder, Board of Directors, equity), Pykus (SAB, equity), Regeneron (CME consultant, ROP Steering Committee, OI for ROP Trial), Retina Today/Pentavision (Consultant), Shapiro Law (ROP expert witness), SLACK (CME consultant), University of Miami (CME consultant), Versl (Founder, equity), Vindico (CME consultant), Visunex (SAB, equity), RESEARCH TO PREVENT BLINDNESS (Dept. Support) and NEI P30-EY026877 (Dept. Support).
Similar articles
-
Predictors of treatment-warranted retinopathy of prematurity in the SUNDROP cohort: influence of photographic features.Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1935-1946. doi: 10.1007/s00417-017-3745-3. Epub 2017 Aug 7. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28782073
-
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening.Acta Ophthalmol. 2010 May;88(3):317-22. doi: 10.1111/j.1755-3768.2009.01715.x. Epub 2009 Nov 20. Acta Ophthalmol. 2010. PMID: 19930212
-
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening.Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):129-36. doi: 10.1007/s00417-008-0943-z. Epub 2008 Sep 11. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 18784936
-
Auckland regional telemedicine retinopathy of prematurity screening network: A 10-year review.Clin Exp Ophthalmol. 2019 Dec;47(9):1122-1130. doi: 10.1111/ceo.13593. Epub 2019 Aug 7. Clin Exp Ophthalmol. 2019. PMID: 31313447 Review.
-
Evaluation of Visunex Medical's PanoCam(TM) LT and PanoCam(TM) Pro wide-field imaging systems for the screening of ROP in newborn infants.Expert Rev Med Devices. 2016 Aug;13(8):705-12. doi: 10.1080/17434440.2016.1208560. Expert Rev Med Devices. 2016. PMID: 27424884 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical